Good shares at cheap prices are what the very best investors look for. At this time of economic turmoil, could Mediclinic International (LON:MDC) be one of them? When it comes to the proven drivers of stock market profits, a blend of "...
MDC — Mediclinic International Share Price
0.000.00%
Last trade - 00:00HealthcareAdventurousMid CapSuper Stock
- £2.40bn
- £4.72bn
- £3.00bn
- 67
- 79
- 84
- 92
Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 12.51 | ||
| PEG Ratio (f) | 0.38 | ||
| EPS Growth (f) | 48.61% | ||
| Dividend Yield (f) | 2.06% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.79 | ||
| Price to Tang. Book | 1.23 | ||
| Price to Free Cashflow | 5.83 | ||
| Price to Sales | 0.76 | ||
| EV to EBITDA | 8.49 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 5.3% | ||
| Return on Equity | 3.97% | ||
| Operating Margin | 10.55% | ||
Financial Summary
| Year End 31st Mar | Unit | 2017 | 2018 | 2019 | 2020 | 2021 | 2022E | 2023E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | £m | 2,749 | 2,876 | 2,932 | 3,083 | 2,995 | 3,200.38 | 3,329.57 | 7.29% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +5.42 | n/a | n/a | +74.26 | -91.41 | +805.47 | +29.47 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health Trend(F-Score)
12345678910
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Latest News & Insights for MDC
Shares in Mediclinic International (LON:MDC) are currently trading at 312.2p, but a key question for investors is how much the current economic uncertainty will affect the price. One way of making that assessment is to look at the prof...
Shares in Mediclinic International (LON:MDC) are currently trading at 296.6p but a key question for investors is how the economic turmoil caused by Covid will continue to affect the price. Part of the answer comes down to judging wheth...
Good shares at cheap prices are what the very best investors look for. At this time of economic turmoil, could Mediclinic International (LON:MDC) be one of them? When it comes to the proven drivers of stock market profits, a blend of "...
Research shows that quality and value are two powerful drivers of stock market profits. After the economic turmoil we've seen over the past year, it's possible that these two factors could have an influence on the Mediclinic Internatio...
Profile Summary
Mediclinic International plc is a United Kingdom-based international private healthcare services company. The Company's segments include Switzerland, Southern Africa and Middle East. The Company is focused on providing specialist-orientated, multi-disciplinary services across the continuum of care. It consists of approximately 74 hospitals, five subacute hospitals, two mental health facilities, 19 day case clinics and 20 outpatient clinics. Its Hirslanden operates approximately 17 hospitals and four day case clinics in Switzerland with around 1900 inpatient beds. Its Mediclinic Southern Africa operates approximately 50 hospitals, five subacute hospitals, two mental health facilities and 13 day case clinics across South Africa, and around 8600 inpatient beds. Its Mediclinic Middle East operates approximately seven hospitals, two day case clinics and 20 outpatient clinics with around 1000 inpatient beds in the United Arab Emirates.
Directors
- Dame K. Beale NEC (57)
- Ronnie Van Der Merwe CEO (57)
- Jurgens Myburgh CFO
- David Hadley CEX
- Daniel Liedtke CEX
- Koert Pretorius CEX (57)
- Magnus Oetiker CHO
- Dirk Le Roux CIO
- Gert Hattingh OTH (54)
- Rene Toua OTH
- Tyson Welzel OTH
- Jannie Durand NED (54)
- James Alan Grieve NED (68)
- Danie Meintjes NED (64)
- Trevor Petersen NED
- Muhadditha Yahya Al Hashimi NID
- Natalia Barsegiyan NID
- Felicity Harvey NID
- Anja Oswald NID
- Tom Singer NID
- Steve Weiner NID
- Last Annual
- March 31st, 2021
- Last Interim
- September 30th, 2021
- Incorporated
- December 20th, 2012
- Public Since
- June 26th, 2013
- No. of Employees
- 33,606
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- London Stock Exchange
- Shares in Issue
- 737,243,810
- Address
- 6th Fl, 65 Gresham Street, LONDON, EC2V 7NQ
- Web
- https://www.mediclinic.com/
- Phone
- +44 2079549600
- Contact
- James Arnold
- Auditors
- PricewaterhouseCoopers LLP
Latest News for MDC
Upcoming Events for MDC
Full Year 2022 Mediclinic International PLC Earnings Release
Similar to MDC
Caretech Holdings
London Stock Exchange
Chill Brands
London Stock Exchange
CVS
London Stock Exchange
Integrated Diagnostics Holdings
London Stock Exchange
IQ-AI
London Stock Exchange
FAQ
What is the Mediclinic International share price?
As of Today at 19:39 UTC, shares in Mediclinic International are trading at 325.80p. This share price information is delayed by 15 minutes.
How has the Mediclinic International share price performed this year?
Shares in Mediclinic International last closed at 325.80p and the price had moved by +8.67% over the past 365 days. In terms of relative price strength the Mediclinic International share price has underperformed the FTSE All Share Index by -3.75% over the past year.
What are the analyst and broker recommendations for Mediclinic International?
The overall consensus recommendation for Mediclinic International is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Mediclinic International dividend yield?
Mediclinic International does not currently pay a dividend.
Does Mediclinic International pay a dividend?
Mediclinic International does not currently pay a dividend.
When does Mediclinic International next pay dividends?
Mediclinic International does not currently pay a dividend.
How do I buy Mediclinic International shares?
To buy shares in Mediclinic International you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Mediclinic International?
As of the previous close price of 325.80p, shares in Mediclinic International had a market capitalisation of £2.40bn.
Where are Mediclinic International shares listed?
Here are the trading details for Mediclinic International:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: MDC
What kind of share is Mediclinic International?
Based on an overall assessment of its quality, value and momentum Mediclinic International is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Mediclinic International share price forecast for 2022?
The analyst consensus target price for shares in Mediclinic International is 376.33p. That is 15.51% above the last closing price of 325.80p.
Analysts covering Mediclinic International currently have a consensus Earnings Per Share (EPS) forecast of £0.21 for the next financial year.
What is the trend in the Mediclinic International share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Mediclinic International. Over the past six months, its share price has outperformed the FTSE All Share Index by +7.52%.
As of the last closing price of 325.80p, shares in Mediclinic International were trading +4.88% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Mediclinic International PE Ratio?
The Mediclinic International PE ratio based on its reported earnings over the past 12 months is 12.51. The shares last closed at 325.80p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Mediclinic International?
Mediclinic International's management team is headed by:
- Dame K. Beale - NEC
- Ronnie Van Der Merwe - CEO
- Jurgens Myburgh - CFO
- David Hadley - CEX
- Daniel Liedtke - CEX
- Koert Pretorius - CEX
- Magnus Oetiker - CHO
- Dirk Le Roux - CIO
- Gert Hattingh - OTH
- Rene Toua - OTH
- Tyson Welzel - OTH
- Jannie Durand - NED
- James Alan Grieve - NED
- Danie Meintjes - NED
- Trevor Petersen - NED
- Muhadditha Yahya Al Hashimi - NID
- Natalia Barsegiyan - NID
- Felicity Harvey - NID
- Anja Oswald - NID
- Tom Singer - NID
- Steve Weiner - NID